Zai Lab Ltd. Sponsored ADR is a company in the U.S. stock market and it is a holding in 56 U.S.-traded ETFs. ZLAB has around 3.3M shares in the U.S. ETF market. The largest ETF holder of ZLAB is the iShares Core MSCI Emerging Markets ETF (IEMG), with approximately 664.14K shares. Investors may also find of interest that the ETF with the largest allocation to ZLAB stock is Global X MSCI China Health Care ETF (CHIH), with a portfolio weight of 5.57%. On average, U.S. ETFs allocate 0.66% of ZLAB to their portfolios.
Additionally, ZLAB is a favorite stock for Vanilla and ESG ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ZLAB as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 45.91%.